Uptake and retention of nitroimidazole-carboranes designed for boron neutron capture therapy in experimental murine tumours: Detection by 11B magnetic resonance spectroscopy

International Journal of Radiation Biology

Volumn 70, Issue 5, 1996, Pages 587-592

  Wood, P J ^a   Scobie, M ^b,c   Threadgill, M D ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b University of Bath   (United Kingdom)

^c Oxford Diversity   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BORON; BORON 11; CARBORANE DERIVATIVE; ORGANOBORON DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUTRON CAPTURE THERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHARMACOKINETICS; PRIORITY JOURNAL;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARCINOMA, SQUAMOUS CELL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR STRUCTURE; NITROIMIDAZOLES; SARCOMA, EXPERIMENTAL;

ANIMALIA; MURINAE;

EID: 0029982109     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530096144798     Document Type: Article

References (27)

1. ADAMS, G. E., AHMED, I., SHELDON, P. W. and STRATFORD, I. J., 1984, Radiation sensitisation and chemopotentiation: RSU1069 a compound more efficient than misonida-zole in vitro and in vivo. British Journal of Cancer, 49, 571-578.
2. BARTH, R. F., SOLOWAY, A. H. and FAIRCHILD, R. G., 1990, Boron neutron capture therapy of cancer. Cancer Research, 50, 1061-1070.
3. BARTH, R. F., SOLOWAY, A. H., FAIRCHILD, R. G. and BRUGGER, R. M., 1992, Boron neutron capture therapy for cancer. Realities and prospects. Cancer, 70, 2995-3007.
4. 2 relaxation and its application to boron-11 imaging of a BNCT agent in an intact rat. Journal of Magnetic Resonance. 88, 369-375.
5. GODERRE, J., RUBIN, P., FREEDMAN, A., HANSEN, J., WOODING, T. S., JOEL, D. and GASH, D., 1994. Selective ablation of rat tumours by boron neutron capture tberapx. International Journal of Radiation Oncology, Biology and Physics, 28, 1067-1077.
6. 14C-misonidazole. British Journal of Radiology. 56, 745-753.
7. GOUDGAON, N. M., ELKATTAN, G. F. and SCHINAZI, R. F., 1994. Boron containing pyrimidines, nucleosides and oligonucleotides for neutron capture therapy. Nucleosides and Nucleotides, 13, 849-880.
8. HATANAKA, H. and NAKAGAWA, Y., 1904, Clinical results of long-surviving brain tumour patients who underwent boron neutron capture therapy. International Journal of Radiation Oncology, Biology, and Physics, 28, 1060-1066.
9. HAWTHORNE, M. F., 1993, The role of chemistry in the development of boron neutron capture therapy of cancer. Angewandte Chemie, International Edition in English, 32, 950-984.
10. 2 tension measure-ments. Cancer Research, 51, 6098-6102.
11. KABALKA, G., W., DAVIS, M. and BENDEI., P., 1988, Boron-11 MRI and MRS of intact animals infused with a boron neutron capture agent. Magnetic Resonance in Medicine, 8, 231-237.
12. 4- in the rat. Magnetic Resonance Imaging, 9, 969-973.
13. KENNEDY, K. A., TEICHER, B. A., ROCKWELL, S. and SARTORELLI, A. C., 1980, The hypoxic tumour cell: a target for selective cancer chemotherapy. Biochemical Pharmacology, 29, 1-8.
14. KEYES, S. R., FRACASSO, P. M., HEIMBROOK, D. C., ROCKWELL, S., SLIGAR, S. G. and SARTORELLI, A. C., 1985, Chemolherapeutic attack of hypoxic cells by the bioreductive agent, mitomycin C. cancer Research, 45, 3042-3645.
15. MIURA, M., GABEL, D., OENBRINK, G. and FAIRCHILD, R. G., 1992. Preparation of carboranyl porphyrins for boron neutron capture therapy. Tetrahedron Letters, 33, 2247-2250.
16. OKUNIEFF, P., HOECKEL, M., DUNPHY, E. P., SCHLENGER, K., KNOOP, C. and VAUPEL, P., 1993, Oxygen tension distributions are sufficient to explain the local response of human breast tumours treated with radiation alone. International Journal of Radiation Oncology Biology and Physics, 26, 631-636.
17. SCOBIE, M. and THREADGILL, M. D, 1994a, Tumour-targetted boranes. Part 3. Synthesis of carbamale-linked nitroimidazole-carboranes designed for boron neutron capture therapy of cancer. Journal of the Chemical Society, Parkin Transactions, 1, 2059-2063.
18. SCOBIE, M. and THREADGILL, M. D., 1994h, Tumour-targetted boranes. 4. Synthesis of nitroimidazole-carboranes with polyether-isoxazolc links, Journal of Organic Chemistry 59, 7008-7013.
19. STRATFORD, I. J., 1992, Bioreductive drugs in cancer therapy. British Journal of Radiology (Suppl. 24), 128-136.
20. STRATFORD, I. J., ADAMS, G. E., BREMNER, J. C. M., COLE, S., EDWARDS, H. E., ROBERTSON, N. and WOOD, P. J., 1994, Manipulation and exploitation of the tumour microenvironment for therapeutic benefit. International Journal of Radiaion Biology, 65, 85-94.
21. SWENSON, D. H., LASTER, B. H. and METZGER, R. L., 1996, Synthesis and evaluation of a boronated nitroimidazole for boron neutron capture therapy. Journal of Medicinal Chemistry, 39, 1540-1541.
22. TJARKS, W., ANSUZZAMAN, A. K. M., LIU, L., SOLOWAY. R. F., BARTH, R. K., PERKINS, D. J. and ADAMS, D. M. 1992. Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy. Journal of Medicinal Chemistry, 35, 1628-1633.
23. TWENTYMAN, P. R., BROWN, J. M., GRAY, J. W., FRANKO, A. L., SCOLE., M. A. and KALLMAN, R. F., 1980, A new mouse tumour model system (RIK-1) for comparison of end-point studies. Journal of the National Cancer Institute, 64, 595-604.
24. WILBUR, D. S., HAMLIN, D. K., LIVESY, J. C., SRIVASTAVA, R. R., LARAMORE, G. E. and GRIFFIN, T. W., 1994, Synthesis and radioiodination of a nido-1,2-carboranyl derivative of 2-nitroimidazole. Nuclear Medicine and Biology, 21, 601-611.
25. G nitro-L-arginine. Cancer Research, 54, 6458-6463.
26. WYZLIC, I. M. and SOLOWAY, A. H., 1992, A general, convenient way to carborane-containing amino acids for boron neutron capture therapy. Tetrahedron Letters, 33, 7489-7490.
27. WYZLIC, I. M., TJARKS, W., SOLOWAY, A. H., ANTSUZZAMAN. A. K. M., RONG., F. G. and BARTH, R. F. (1994). Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy. International Journal of Radiation Oncology, Biology and Physics, 28, 1203-1214.